“Bank of America analysts calculate that the oral version needs about 2,000 prescriptions per week in order for the company to meet 2026 sales estimates.”
It will be interesting to see how much pent-up demand there is in those week 2 figures. Have many been waiting specifically for the pill to arrive on the market?
That ratio, where Wegovy prescriptions are 2x Zepbound’s, sounds very promising. I could also imagine that for telehealth services, the threshold for obtaining a prescription for a pill is lower than for an injection.
EDIT(2):
I checked the Google Trends data again, and searches for Wegovy are on the rise. These are not directly comparable to each other, but rather illustrate the search term’s trend.
